<table id="ID137" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="32%"></col>
<col width="68%"></col>
<thead>
<tr>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Interacting </content>
<content stylecode="bold">Drug</content>
<br/>
</td>
<td align="left" colspan="1" stylecode=" Lrule Rrule Botrule Toprule" valign="top">
<content stylecode="bold">Interaction</content>
<content stylecode="bold">
<br/>
</content>
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Drugs known to prolong <br/>QT interval (e.g., Class IA <br/>and Class III antiarrhythmic <br/>agents).<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Quinine sulfate prolongs  QT interval,  ECG abnormalities including  QT prolongation and  Torsades de Pointes.  Avoid concomitant use (<linkhtml href="#ID101">5.3</linkhtml>). </td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Other antimalarials <br/>(e.g., halofantrine, <br/>mefloquine).<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">ECG abnormalities including  QT prolongation Avoid concomitant  use (<linkhtml href="#ID101">5.3</linkhtml>, <linkhtml href="#ID127">7.2</linkhtml>). </td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">CYP3A4 inducers or <br/>inhibitors<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Alteration in plasma  quinine concentration.  Monitor for lack of efficacy  or increased adverse events of  quinine (<linkhtml href="#ID121">7.1</linkhtml>). </td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">CYP3A4 and <br/>CYP2D6 substrates<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Quinine is an inhibitor of  CYP3A4 and CYP2D6.  Monitor for lack of efficacy  or increased adverse events  of the co-administered  drug (<linkhtml href="#ID127">7.2</linkhtml>). </td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Digoxin<br/>
</td>
<td align="left" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Increased digoxin  plasma concentration (<linkhtml href="#ID111">5.8</linkhtml>, <linkhtml href="#ID121">7.1</linkhtml>). </td>
</tr>
</tbody>
</table>